Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-26-065944
Filing Date
2026-05-26
Accepted
2026-05-26 06:27:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm2615433-1_424b5.htm 424B5 698508
2 GRAPHIC lg_editasmedicine-4c.jpg GRAPHIC 27738
  Complete submission text file 0001104659-26-065944.txt   737858
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-277471 | Film No.: 261015856
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)